ATR vs NVS
AptarGroup vs Novartis AG — AI-powered side-by-side comparison
| Metric | ATR | NVS |
|---|
| AI Score |
69
|
75
|
| Price |
$134.62
|
$154.64
|
| P/E Ratio |
24.06×
|
23.55×
|
| ROE |
14.7%
|
30.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
28.3%
|
74.3%
|
| Debt / Equity |
0.54×
|
1.18×
|
| Dividend Yield |
1.4%
|
2.9%
|
| RSI (14) |
48.2
|
57.7
|
| Beta |
0.382
|
0.462
|
| Expected Upside |
+1.6%
|
+2.4%
|
AI Committee View
Current Innellis committee reasoning for ATR versus NVS.
NVS leads by 6 points.
NVS scores 75/100 (Buy) versus ATR at 69/100 (Buy).
ATR Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
NVS Committee View
100% agreement
5 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical